enterotoxigenic E. coli
Showing 1 - 25 of 4,297
Diarrhea, Travelers Diarrhea, Infectious Diarrhea Trial in Baltimore (Travelan, Placebo)
Recruiting
- Diarrhea
- +2 more
- Travelan
- Placebo
-
Baltimore, MarylandPharmaron Clinical Pharmacology Center
Jul 5, 2023
Enterotoxigenic Escherichia Coli Infection, Diarrhea Trial in Baltimore (VLA1701, Placebo, Challenge Strain)
Completed
- Enterotoxigenic Escherichia Coli Infection
- Diarrhea
- VLA1701
- +2 more
-
Baltimore, MarylandDepartment of International Health Johns Hopkins University
Mar 29, 2021
Shigella Infection, Enterotoxigenic Escherichia Coli Infection Trial in Baltimore (strain CVD 1208S-122, Placebo)
Not yet recruiting
- Shigella Infection
- Enterotoxigenic Escherichia Coli Infection
- strain CVD 1208S-122
- Placebo
-
Baltimore, MarylandUniversity of Maryland, Baltimore, University of Maryland School
Jul 26, 2022
Escherichia Coli Infection Trial in Silver Spring (Recombinant fimbrial adhesin dsc14CfaE-sCTA2/LTB5, Recombinant fimbrial
Completed
- Escherichia Coli Infection
- Recombinant fimbrial adhesin dsc14CfaE-sCTA2/LTB5
- +2 more
-
Silver Spring, MarylandWalter Reed Army Institute of Research Clinical trial Center
Feb 10, 2021
Gastroenteritis Escherichia Coli, Immunisation Trial in Dhaka (Placebo, Recombinant Double Mutant Heat-Labile Toxin
Terminated
- Gastroenteritis Escherichia Coli
- Immunisation
- Placebo
- Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral enterotoxigenic Escherichia coli (ETEC) Vaccine
-
Dhaka, BangladeshInternational Center for Diarrheal Disease Research Bangladesh -
Dec 16, 2021
Diabetes Trial in Amsterdam (EcN Colibactin knockout, E Coli Nissle)
Not yet recruiting
- Diabetes
- EcN Colibactin knockout
- E Coli Nissle
-
Amsterdam, NetherlandsAmsterdam UMC location AMC
Apr 4, 2023
Perinatal Transmission of MDR Bacteria
Recruiting
- E. Coli Infection
- Multi-antibiotic Resistance
-
Chicago, IllinoisPrentice Women's Hospital
Nov 20, 2023
Bacterial Growth, Novel Influenza A (H1N1) Trial in Jilin (A novel electrolyzed water spray reduces numbers of bacteria E-coli
Recruiting
- Bacterial Growth
- Novel Influenza A (H1N1)
- A novel electrolyzed water spray reduces numbers of bacteria E-coli and an attenuated human flu virus on human hands
-
Jilin, Changchun, ChinaChangchun Jiahe Surgery Hospital
Apr 1, 2023
Urinary Tract Infections Trial in Nantes (Dissemination of a selective reporting for antibiotic susceptibility testing, Standard
Not yet recruiting
- Urinary Tract Infections
- Dissemination of a selective reporting for antibiotic susceptibility testing
- Standard antibiotic susceptibility testing report
-
Nantes, FranceUniversity Hospital
Sep 28, 2023
Urinary Tract Infections in Children, Secondary Prevention Trial in Finland (E. coli Nissle, Placebo control)
Recruiting
- Urinary Tract Infections in Children
- Secondary Prevention
- E. coli Nissle
- Placebo control
-
Helsinki, Finland
- +4 more
Jul 5, 2022
Diarrhea Trial in Helsinki (E. coli ETVAX, Placebo)
Completed
- Diarrhea
- E. coli ETVAX
- Placebo
-
Helsinki, FinlandLääkärikeskus Aava, matkailuklinikka
Nov 6, 2019
E. Coli Isolates From Recurrent Urinary Tract Infections
Not yet recruiting
- Urinary Tract Infections
- +2 more
- collection of bacterial strains
- (no location specified)
Apr 24, 2023
Polio Trial in Antwerpen (IMOVAX Inactivated Poliomyelitis Vaccine (IPV), dmLT (adjuvant), Bivalent oral polio vaccine (bOPV))
Completed
- Polio
- Inactivated Poliomyelitis Vaccine (IPV)
- +2 more
-
Antwerpen, Wilrijk, BelgiumUniversity of Antwerpen
Apr 5, 2022
Crohn Disease Trial in New York (Placebo, Bacteriophage preparation)
Recruiting
- Crohn Disease
- Placebo
- Bacteriophage preparation
-
New York, New YorkThe Mount Sinai Hospital
Jan 6, 2023
Diarrhea Trial in Silver Spring (CssBA, dmLT)
Completed
- Diarrhea
- CssBA
- dmLT
-
Silver Spring, MarylandWalter Reed Army Institute of Research Clinical Trial Center
Dec 10, 2020
Urinary Tract Infections Trial in United States (LBP-EC01, Placebo)
Advancing Age and Mortality at 30 Days in Bacteremia E. Coli
Completed
- Beta-lactamase Extended Spectrum, E. Coli, Elderly, Mortality, Risk Factor
-
Nantes, FranceCHU Nantes
Sep 20, 2021
Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection, Hemolytic-Uremic Syndrome Trial in Canada, United States (Infusion
Recruiting
- Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection
- Hemolytic-Uremic Syndrome
- Infusion of 200% maintenance fluids as balanced crystalloid IV solution
- Oral fluids; infusion of up to 110% maintenance fluids as balanced crystalloid IV solution
-
Birmingham, Alabama
- +25 more
Sep 19, 2022
Developing Microbials to Fight Extended-spectrum
Active, not recruiting
- Extended Spectrum Beta Lactamases (ESBL) E. Coli
- examination of stool sample
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Clinical Microbiology
Aug 3, 2021
Crohn Disease Trial (Fecal Microbiota Transplantation)
Not yet recruiting
- Crohn Disease
- Fecal Microbiota Transplantation
- (no location specified)
Nov 9, 2022
Collect Information About Invasive Disease Caused by
Completed
- E. Coli Infection
-
Durham, North Carolina
- +7 more
Sep 20, 2021
Sanitation and Oral Rotavirus Vaccine Performance
Recruiting
- Rotavirus Infections
- +2 more
- Sanitation
-
Maputo, MozambiqueCentro de Investigação em Saúde da Polana Caniço (CISPOC)
May 16, 2022
Hepatitis E Infection Trial in Karachi (Hecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli))., Isotonic Sodium Chloride
Not yet recruiting
- Hepatitis E Infection
- Hecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli)).
- Isotonic Sodium Chloride injection
-
Karachi, Sindh, PakistanThe Aga Khan University
Mar 29, 2023
E.Coli Infections, Bloodstream Infection Trial in Cincinnati (SNIPR001, Placebo)
Active, not recruiting
- E.Coli Infections
- Bloodstream Infection
- SNIPR001
- Placebo
-
Cincinnati, OhioMedpace Clinical Pharmacology
Dec 1, 2022